Autolus Therapeutics plc Files 8-K on Shareholder Matters
Ticker: AUTL · Form: 8-K · Filed: Jun 27, 2025 · CIK: 1730463
| Field | Detail |
|---|---|
| Company | Autolus Therapeutics PLC (AUTL) |
| Form Type | 8-K |
| Filed Date | Jun 27, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: corporate-governance, shareholder-vote
Related Tickers: AUTL
TL;DR
Autolus filed an 8-K on shareholder votes. All good.
AI Summary
Autolus Therapeutics plc filed an 8-K on June 27, 2025, reporting on matters submitted to a vote of security holders as of June 26, 2025. The filing details the company's corporate structure and operational information, including its principal executive offices in London, United Kingdom.
Why It Matters
This filing provides an update on corporate governance and shareholder decisions for Autolus Therapeutics, which is crucial for investors to understand the company's direction and management.
Risk Assessment
Risk Level: low — The filing is a routine corporate disclosure and does not contain information about significant financial events or operational changes that would inherently increase risk.
Key Players & Entities
- Autolus Therapeutics plc (company) — Registrant
- June 26, 2025 (date) — Date of earliest event reported
- June 27, 2025 (date) — Date of Report
- London (location) — Principal executive offices
FAQ
What is the primary purpose of this 8-K filing?
The primary purpose of this 8-K filing is to report on matters submitted to a vote of security holders as of June 26, 2025.
What is the exact name of the registrant?
The exact name of the registrant is Autolus Therapeutics plc.
In which jurisdiction was Autolus Therapeutics plc incorporated or organized?
Autolus Therapeutics plc was incorporated or organized in England and Wales.
What is the address of the registrant's principal executive offices?
The address of the registrant's principal executive offices is The Mediaworks, 191 Wood Lane, London, W12 7FP, United Kingdom.
What is the telephone number of the registrant, including area code?
The registrant's telephone number, including area code, is (44) 20 3829 6230.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on June 27, 2025 regarding Autolus Therapeutics plc (AUTL).